{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:45:20Z","timestamp":1761101120893},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:00:00Z","timestamp":1372464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12185-013-1383-z","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T05:31:55Z","timestamp":1372397515000},"page":"171-178","source":"Crossref","is-referenced-by-count":6,"title":["A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group"],"prefix":"10.1007","volume":"98","author":[{"given":"Yoshihiro","family":"Torimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Inamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuhei","family":"Koda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Shinzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishu","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kohgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,29]]},"reference":[{"key":"1383_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.critrevonc.2010.07.007","volume":"79","author":"KJ Savage","year":"2011","unstructured":"Savage KJ, Ferreri AJ, Zinzani PL, et al. Peripheral T-cell lymphoma\u2014not otherwise specified. Cri Rev Oncol Hematol. 2011;79:321\u20139.","journal-title":"Cri Rev Oncol Hematol."},{"key":"1383_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hon.836","volume":"26","author":"D Rodriguez-Abreu","year":"2008","unstructured":"Rodriguez-Abreu D, Filho VB, Zucca E. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Hematol Oncol. 2008;26:8\u201320.","journal-title":"Hematol Oncol"},{"key":"1383_CR3","doi-asserted-by":"crossref","unstructured":"Foss FM, Zinzani PL, Vose JM, et al. Peripheral T-cell lymphoma. Blood. 2011;117:6756\u201367.","DOI":"10.1182\/blood-2010-05-231548"},{"key":"1383_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11899-011-0100-3","volume":"6","author":"KJ Savage","year":"2011","unstructured":"Savage KJ. Update: peripheral T-Cell lymphomas. Curr Hematol Malig Rep. 2011;6:222\u201330.","journal-title":"Curr Hematol Malig Rep."},{"key":"1383_CR5","doi-asserted-by":"crossref","unstructured":"The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50:696\u2013702.","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"1383_CR6","doi-asserted-by":"crossref","unstructured":"Weisenburger DD, Kerry J. Savage KJ, Nancy Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117: 3402\u20138.","DOI":"10.1182\/blood-2010-09-310342"},{"key":"1383_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329:987\u201394.","journal-title":"N Engl J Med"},{"key":"1383_CR8","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"Andrea Gallamini","year":"2004","unstructured":"Gallamini Andrea, Stelitano Caterina, Calvi Roberta, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103:2474\u20139.","journal-title":"Blood"},{"key":"1383_CR9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","volume":"29","author":"N Asano","year":"2005","unstructured":"Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell Lymphoma, unspecified. Am J Surg Pathol. 2005;29:1284\u201393.","journal-title":"Am J Surg Pathol"},{"key":"1383_CR10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.leukres.2004.04.016","volume":"28","author":"H Kojima","year":"2004","unstructured":"Kojima H, Hasegawa Y, Suzukawa K, et al. Clinicopathological features and prognostic factors of Japanese patients with \u201cperipheral T-cell lymphoma, unspecified\u201d diagnosed according to the WHO classification. Leuk Res. 2004;28:1287\u201392.","journal-title":"Leuk Res"},{"key":"1383_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00432-008-0440-0","volume":"135","author":"J Kitagawa","year":"2009","unstructured":"Kitagawa J, Hara T, Tsurumi H, et al. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U). Cancer Res Clin Oncol. 2009;135:53\u20139.","journal-title":"Cancer Res Clin Oncol."},{"key":"1383_CR12","volume-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.","edition":"4"},{"key":"1383_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"1383_CR14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244\u201353.","journal-title":"J Clin Oncol"},{"key":"1383_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"1383_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc B."},{"key":"1383_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","volume":"88","author":"Y Lee","year":"2009","unstructured":"Lee Y, Uhm JE, Lee HY, et al. Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d. Ann Hematol. 2009;88:111\u20139.","journal-title":"Ann Hematol"},{"key":"1383_CR18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2008.07.010","volume":"5","author":"JM Vose","year":"2008","unstructured":"Vose JM. Peripheral T-cell non-Hodgkin\u2019s lymphoma. Hematol Oncol Clin North Am. 2008;5:997\u20131005.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1383_CR19","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007;110:2316\u201323.","journal-title":"Blood"},{"key":"1383_CR20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28:1591\u20138.","journal-title":"J Clin Oncol"},{"key":"1383_CR21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","volume":"29","author":"OA O\u2019Connor","year":"2011","unstructured":"O\u2019Connor OA, Pro B, Pinter-Brown L, et al. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol. 2011;29:1182\u20139.","journal-title":"J Clin Oncol"},{"key":"1383_CR22","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz RL, Frye R, Prince HM, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood. 2011;117:5827\u201334.","journal-title":"Blood"},{"issue":"8","key":"1383_CR23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3109\/10428194.2011.573031","volume":"52","author":"PL Zinzani","year":"2011","unstructured":"Zinzani PL, Pellegrini C, Broccoli A, et al. Lenalidomide monotherapy for relapsed\/refractory peripheral T-cell lymphoma not otherwise specified. Leuk Lymphoma. 2011;52(8):1585\u20138.","journal-title":"Leuk Lymphoma"},{"key":"1383_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ctrv.2012.03.011","volume":"39","author":"J Yared","year":"2013","unstructured":"Yared J, Kimball A. The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: a review of the literature and new perspectives. Cancer Treat Rev. 2013;39:51\u20139.","journal-title":"Cancer Treat Rev"},{"key":"1383_CR25","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F, Relander T, Lauritzsen GF, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30:3093\u20139.","journal-title":"J Clin Oncol"},{"key":"1383_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","volume":"27","author":"P Reimer","year":"2009","unstructured":"Reimer P, Rudiger T, Geissinger E, et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27:106\u201313.","journal-title":"J Clin Oncol"},{"key":"1383_CR27","first-page":"4477","volume":"118","author":"J Ahn","year":"2011","unstructured":"Ahn J, Yang D, Chae YS, et al. Frontline autologous stem cell transplantation as intensive consolidation in patients with peripheral T cell lymphomas: multicenter phase II trial in Korea. ASH Ann Meeting Abstr. 2011;118:4477.","journal-title":"ASH Ann Meeting Abstr"},{"key":"1383_CR28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, et al. Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008;19:958\u201363.","journal-title":"Ann Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1383-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1383-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1383-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:44:55Z","timestamp":1715579095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1383-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,29]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1383-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,29]]}}}